| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.191 | 7.253 | 3.798 | 8.387 | 0 | 0 | 0 | 945 | 0 | 0 |
| Total Income - EUR | 36.193 | 8.342 | 3.798 | 16.241 | 0 | 0 | 161 | 945 | 0 | 0 |
| Total Expenses - EUR | 43.562 | 13.127 | 8.962 | 13.596 | 68 | 7 | 462 | 71 | 143 | 0 |
| Gross Profit/Loss - EUR | -7.370 | -4.785 | -5.164 | 2.645 | -68 | -7 | -301 | 874 | -143 | 0 |
| Net Profit/Loss - EUR | -7.370 | -4.899 | -5.202 | 2.482 | -68 | -7 | -306 | 846 | -143 | 0 |
| Employees | 4 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hipocrate Laborator De Analize Medicale S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.562 | 1.149 | 752 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.596 | 3.931 | 3.783 | 5.945 | 5.356 | 5.239 | 4.676 | 5.536 | 5.371 | 5.341 |
| Inventories | 526 | 49 | 40 | 0 | 9 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.366 | 3.523 | 3.397 | 1.051 | 1.031 | 1.011 | 989 | 1.936 | 989 | 983 |
| Cash | 4.704 | 359 | 347 | 4.894 | 4.316 | 4.228 | 3.687 | 3.600 | 4.382 | 4.358 |
| Shareholders Funds | 5.261 | 308 | -4.899 | -2.327 | -2.349 | -2.311 | -2.566 | -1.729 | -1.866 | -1.856 |
| Social Capital | 56 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 3.897 | 4.772 | 9.434 | 8.286 | 7.705 | 7.550 | 7.242 | 7.265 | 7.238 | 7.197 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Hipocrate Laborator De Analize Medicale S.r.l.